Skip to main content
. 2022 Nov 23;17(11):e0276824. doi: 10.1371/journal.pone.0276824

Table 2. Associations between cannabis use in pregnancy and maternal and infant outcomes, BC, ON and NL, 2012–2019.

Maternal and Infant Outcomes Cannabis use No cannabis use p-value Unadjusted Odds Ratios (95% CI) Adjusted Oddsa Ratios (95% CI) Adjusted Oddsa Ratios (95% CI)–Female Infant Adjusted Oddsa Ratios (95% CI)–Male Infant Interaction p-value
n % n %
Preterm (<37 weeks) 1751 9.1 41128 4.2 <0.0001 2.30 1.85 1.88 1.82 0.05
[2.19–2.42] [1.74–1.94] [1.74–2.04] [1.69–1.96]
    Spontaneous 1097 5.7 24004 2.4 <0.0001 2.47 1.80 1.94 1.70 0.04
[2.32–2.63] [1.68–1.93] [1.76–2.14] [1.55–1.86]
Medically 654 3.4 17124 1.7 <0.0001 2.06 1.94 1.80 2.06 0.1
Indicated [1.90–2.23] [1.77–2.12] [1.59–2.05] [1.83–2.30]
Very preterm (<32 weeks) 198 1.0 3992 0.4 <0.0001 2.56 1.73 1.87 1.62 0.3
[2.21–2.95] [1.48–2.02] [1.50–2.33] [1.31–2.00]
Low birthweight (<2500g) 1292 6.7 23942 2.4 <0.0001 2.89 1.90 1.88 1.93 0.7
[2.73–3.06] [1.79–2.03] [1.73–2.05] [1.77–2.11]
SGA (<10th percentile) 2360 12.3 73128 7.4 <0.0001 1.72 1.21 1.28 1.16 0.03
[1.65–1.80] [1.16–1.27] [1.20–1.37] [1.08–1.23]
LGA (>90th percentile) 1547 8.1 95430 9.7 <0.0001 0.86 1.06 1.09 1.03 0.3
[0.82–0.91] [1.01–1.12] [1.01–1.18] [0.96–1.12]
Stillbirth 60 0.3 1997 0.2 0.001 1.53 1.15 1.14 1.13 1.0
[1.18–1.98] [0.86–1.53] [0.74–1.75] [0.77–1.66]
Any major congenital anomaly 246 1.2 6287 0.6 <0.0001 1.99 1.71 1.89 1.63 0.3
[1.75–2.26] [1.49–1.97] [1.51–2.36] [1.38–1.93]
Caesarean section 4324 22.9 240013 24.7 <0.0001 0.90 1.13 * * *
[0.87–0.93] [1.09–1.17]
Gestational diabetes 883 4.6 56317 5.7 <0.0001 0.79 1.32 * * *
[0.74–0.85] [1.23–1.42]b
Gestational hypertension 455 2.4 21231 2.2 0.048 1.10 1.10 * * *
[1.001–1.21] [0.99–1.22]c

*Comparisons by infant sex were only conducted for infant outcomes.

a Models adjusted for other substance use, maternal age, pre-pregnancy BMI, rural maternal residence, parity, QAIPPE score, pre-existing diabetes, chronic hypertension, gestational diabetes and gestational hypertension.

b Models adjusted for other substance use, maternal age, pre-pregnancy BMI, rural maternal residence, parity, QAIPPE score, pre-existing diabetes, chronic hypertension and gestational hypertension.

c Models adjusted for other substance use, maternal age, pre-pregnancy BMI, rural maternal residence, parity, QAIPPE score, pre-existing diabetes, chronic hypertension and gestational diabetes.